1-11 of 11
Jörg Thomalla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Clonal Heterogeneity in Newly Diagnosed, Transplant-Eligible Multiple Myeloma - Subgroup Analysis of the GMMG HD6 Phase III Trial

Maximilian Merz, Ema Pozek, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Julia Krzykalla, Roland Fenk, Jana Schlenzka, Markus Munder, Christine Hanoun, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Igor Wolfgang Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christina Kunz, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe Martens, Manfred Hensel, Axel Benner, Andrea Seidel-Glätzer, Katja C. Weisel, Marc S. Raab, Hans Salwender, Hartmut Goldschmidt, Elias K. Mai
Journal: Blood
Blood (2024) 144 (Supplement 1): 84.
https://doi.org/10.1182/blood-2024-201972
Published: 2024
Journal Articles

Quality of Life in the Multicenter, Randomized, Phase 3 GMMG-HD6 Trial Applying Elotuzumab, Lenalidomide, Bortezomib and Dexaemethason in Patients with Newly-Diagnosed Multiple Myeloma

Anna Fleischer, Elias K. Mai, Kaya Miah, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Christine Hanoun, Igor Wolfgang Blau, Christoph Mann, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe Martens, Christian Kunz, Manfred Hensel, Marc S. Raab, Katja C. Weisel, Hans Salwender, Imad Maatouk, Hartmut Goldschmidt
Journal: Blood
Blood (2024) 144 (Supplement 1): 1963.
https://doi.org/10.1182/blood-2024-205230
Published: 2024
Journal Articles

Immunological Subgroups Predicting Efficacy of Elotuzumab in Multiple Myeloma Patients: Insights from the GMMG-HD6 Clinical Trial

Gigi Nu Hoang Quy Ton, Katharina Kriegsmann, Mohamed H.S. Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Jana Schlenzka, Markus Munder, Jan Dürig, Igor Wolfgang Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Andreas Neubauer, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja Weisel, Hans Salwender, Carsten Müller-Tidow, Marc S. Raab, Hartmut Goldschmidt, Elias K. Mai, Michael Hundemer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1991.
https://doi.org/10.1182/blood-2023-189169
Published: 2023
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care 1995 - 2017

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Hubert Köppler, Prof., Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4823.
https://doi.org/10.1182/blood-2018-99-109862
Published: 2018
Journal Articles

Reality of Care for Patients with Multiple Myeloma 1995-2016. New Drugs in Routine Care Lead to Improved Survival

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5628.
https://doi.org/10.1182/blood.V130.Suppl_1.5628.5628
Published: 2017
Journal Articles

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Rüdiger Hehlmann, MD, Michael Lauseker, PhD, Susanne Saussele, MD, Markus Pfirrmann, Stefan W. Krause, MD, Hans-Jochem Kolb, MD, Andreas Neubauer, MD, Dieter K. Hossfeld, Christoph Nerl, MD, Alois Gratwohl, MD, Gabriela M. Baerlocher, Dominik Heim, MD, Tim Henrik Bruemmendorf, Alice Fabarius, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martin C. Müller, MD, Sabine Jeromin, PhD, Ulrike Proetel, PhD, Katharina Kohlbrenner, PhD, Astghik Voskanyan, PhD, Sébastien Rinaldetti, Wolfgang Seifarth, PhD, Birgit Spiess, Leopold Balleisen, MD, Maria E Goebeler, MD, Mathias Hänel, MD, Anthony D. Ho, MD, J Dengler, C Falge, Lothar Kanz, MD, Claus-Henning Köhne, MD, PhD, Andreas Burchert, MD, Michael Kneba, MD PhD, Frank Stegelmann, MD, C Köhne, Hans-Walter Lindemann, C Waller, Michael Pfreundschuh, MD, Karsten Spiekermann, Wolfgang E Berdel, MD, L Müller, Matthias Edinger, MD, Jiri Mayer, Prof, MD SCs, Dietrich W Beelen, MD PhD, Martin Bentz, MD, Hartmut Link, MDPhD, Bernd Hertenstein, MD, R Fuchs, Martin Wernli, MD, F Schlegel, Rudolph Schlag, M de Wit, Lorenz Trümper, MD, H Hebarth, M Hahn, Jörg Thomalla, MD, Christof Scheid, MD, Philippe Schafhausen, MD, Walter Verbeek, MD, Michael J. Eckart, MD, Winfried Gassmann, MD PhD, Antonio Pezzutto, MD, Michael Schenk, Peter Brossart, MD, Thomas Geer, MD, Stephan Bildat, E Schäfer, Andreas Hochhaus, MD, Joerg Hasford
Journal: Blood
Blood (2017) 130 (Supplement 1): 897.
https://doi.org/10.1182/blood.V130.Suppl_1.897.897
Published: 2017
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care. a Retrospective Analysis of All Patients with CLL Who Were Treated in an Oncology Group Practice in Germany Between 1995-2015

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD, Hubert Köppler, Prof.
Journal: Blood
Blood (2016) 128 (22): 5961.
https://doi.org/10.1182/blood.V128.22.5961.5961
Published: 2016
Journal Articles

Treatment Reality of Patients with Immune Thrombocytopenia (ITP) in Routine Care

Rudolf Weide, MD, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Prof. Dr.
Journal: Blood
Blood (2014) 124 (21): 5009.
https://doi.org/10.1182/blood.V124.21.5009.5009
Published: 2014
Journal Articles

Bendamustine + Rituximab-Combinations and R-CHOP Achieve a Major Survival Improvement Of Patients With Follicular Lymphoma In Routine Care

Rudolf Weide, Prof. Dr., Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Prof. Dr.
Journal: Blood
Blood (2013) 122 (21): 5584.
https://doi.org/10.1182/blood.V122.21.5584.5584
Published: 2013
Journal Articles

Bendamustine and Rituximab Achieve a Major Survival Improvement Of Patients With Morbus Waldenström In Routine Care

Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler
Journal: Blood
Blood (2013) 122 (21): 5611.
https://doi.org/10.1182/blood.V122.21.5611.5611
Published: 2013
Journal Articles

Sequential Treatment With Bendamustine, Rituximab, Chlorambucil and Fludarabine Leads To a Major Survival Improvement Of Patients With Chronic Lymphocytic Leukemia (CLL) In Routine Care

Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler
Journal: Blood
Blood (2013) 122 (21): 5613.
https://doi.org/10.1182/blood.V122.21.5613.5613
Published: 2013